The International Liver Tumor Group RAS-trial Radiofrequency Ablation Versus Stereotactic Body Radiation Therapy for Colorectal Liver Metastases: A Randomized Trial
Patients with 1-4 inoperable colorectal liver metastases, no more 4 cm in diameter are
randomized to either RFA or SBRT. Primary end point i local progression free survival.
Chemotherapy is allowed before and after study treatment.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Local progression-free survival
Morten Høyer, MD PhD
Aarhus University Hospital
Sweden: Regional Ethical Review Board